2011
DOI: 10.1002/jps.22386
|View full text |Cite
|
Sign up to set email alerts
|

Polymorphism and Solvatomorphism 2009

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
40
0
1

Year Published

2011
2011
2015
2015

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 40 publications
(41 citation statements)
references
References 170 publications
0
40
0
1
Order By: Relevance
“…On account of this, prediction and precise control of a specific polymorph are critical for achieving desired solubility and stability requirement. Recent efforts have been devoted to the development of consistent and reliable crystallization processes for producing desirable polymorphs, including on-line, spectroscopy-based monitoring designs of crystal growth in solution (3)(4)(5). Polymorphic formation is known to be affected by a wide variety of growth conditions, such as type of solvent (6)(7)(8), supersaturation (4,9), temperature (10), and use of additives (11,12).…”
Section: Introductionmentioning
confidence: 99%
“…On account of this, prediction and precise control of a specific polymorph are critical for achieving desired solubility and stability requirement. Recent efforts have been devoted to the development of consistent and reliable crystallization processes for producing desirable polymorphs, including on-line, spectroscopy-based monitoring designs of crystal growth in solution (3)(4)(5). Polymorphic formation is known to be affected by a wide variety of growth conditions, such as type of solvent (6)(7)(8), supersaturation (4,9), temperature (10), and use of additives (11,12).…”
Section: Introductionmentioning
confidence: 99%
“…2 Hydrates and solvates have additionally received much attention. 3 Co-crystals, in which the neutral API is combined with a neutral co-former in a single crystalline phase, have been shown to be capable of improving physical, mechanical, dissolution and bioavailability properties for a range of APIs. 4 For instance, the hygroscopicity of theophylline can be reduced through forming co-crystals with oxalic acid.…”
Section: Introductionmentioning
confidence: 99%
“…7 Some illuminating examples of conversions such as described above can be found in literature. 8,9 For example, the milling process of cimetidine enables conversions of forms B and C to form A, whereas form A transforms into form D only upon nucleation. In all cases, the particle size reduction step resulted in substantial formation of an amorphous phase.…”
Section: Introductionmentioning
confidence: 99%